SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-24-045039
Filing Date
2024-04-09
Accepted
2024-04-09 09:35:25
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm249796d2_defa14a.htm DEFA14A 11799
2 GRAPHIC tm249796d2_defa14aimg001.jpg GRAPHIC 380229
3 GRAPHIC tm249796d2_defa14aimg002.jpg GRAPHIC 226000
  Complete submission text file 0001104659-24-045039.txt   848083
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39231 | Film No.: 24831395
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)